|
Orticumab Clinical Trials
1 actively recruiting trial across 1 location
Also known as: BI204, MLDL1278a
Los Angeles, California1 trial
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Abcentra Investigational Site
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.